186 related articles for article (PubMed ID: 16112273)
1. Cytokine recognition by human interleukin 5 receptor.
Ishino T; Robertson N; Chaiken I
Vitam Horm; 2005; 71():321-44. PubMed ID: 16112273
[TBL] [Abstract][Full Text] [Related]
2. Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha.
Ruchala P; Varadi G; Ishino T; Scibek J; Bhattacharya M; Urbina C; Ryk DV; Uings I; Chaiken I
Biopolymers; 2004 Apr; 73(5):556-68. PubMed ID: 15048779
[TBL] [Abstract][Full Text] [Related]
3. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains.
England BP; Balasubramanian P; Uings I; Bethell S; Chen MJ; Schatz PJ; Yin Q; Chen YF; Whitehorn EA; Tsavaler A; Martens CL; Barrett RW; McKinnon M
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6862-7. PubMed ID: 10823900
[TBL] [Abstract][Full Text] [Related]
4. The solution structure of the cytokine-binding domain of the common beta-chain of the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5.
Mulhern TD; Lopez AF; D'Andrea RJ; Gaunt C; Vandeleur L; Vadas MA; Booker GW; Bagley CJ
J Mol Biol; 2000 Apr; 297(4):989-1001. PubMed ID: 10736232
[TBL] [Abstract][Full Text] [Related]
5. Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5.
Li C; Plugariu CG; Bajgier J; White JR; Liefer KM; Wu SJ; Chaiken I
J Mol Recognit; 2002; 15(1):33-43. PubMed ID: 11870920
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-5 receptor alpha-chain binding assays: use for screening and analysis of interleukin-5 mutants.
Banks M; Graber P; Proudfoot AE; Arod CY; Allet B; Bernard AR; Sebille E; McKinnon M; Wells TN; Solari R
Anal Biochem; 1995 Sep; 230(2):321-8. PubMed ID: 7503425
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic mutant proteins of interleukin-4.
Duschl A; Müller T; Sebald W
Behring Inst Mitt; 1995 Jun; (96):87-94. PubMed ID: 7575356
[TBL] [Abstract][Full Text] [Related]
8. Delineation of IL-5 domains predicted to engage the IL-5 receptor complex.
Dickason RR; Huston MM; Huston DP
J Immunol; 1996 Feb; 156(3):1030-7. PubMed ID: 8557976
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of human IL-13 and implication for receptor binding.
Moy FJ; Diblasio E; Wilhelm J; Powers R
J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the interleukin-5 receptor antagonist peptide, AF18748.
Rosas M; Uings IJ; van Aalst C; Lammers JW; Koenderman L; Coffer PJ
Cytokine; 2004 Jun; 26(6):247-54. PubMed ID: 15183842
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin-5].
Yamaguchi Y
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1287-93. PubMed ID: 8031174
[TBL] [Abstract][Full Text] [Related]
12. IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor.
Murphy JM; Young IG
Vitam Horm; 2006; 74():1-30. PubMed ID: 17027509
[TBL] [Abstract][Full Text] [Related]
13. Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5Rα.
Patino E; Kotzsch A; Saremba S; Nickel J; Schmitz W; Sebald W; Mueller TD
Structure; 2011 Dec; 19(12):1864-75. PubMed ID: 22153509
[TBL] [Abstract][Full Text] [Related]
14. The structure of interleukin-2 complexed with its alpha receptor.
Rickert M; Wang X; Boulanger MJ; Goriatcheva N; Garcia KC
Science; 2005 Jun; 308(5727):1477-80. PubMed ID: 15933202
[TBL] [Abstract][Full Text] [Related]
15. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
Wang X; Rickert M; Garcia KC
Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
[TBL] [Abstract][Full Text] [Related]
16. A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5.
Milburn MV; Hassell AM; Lambert MH; Jordan SR; Proudfoot AE; Graber P; Wells TN
Nature; 1993 May; 363(6425):172-6. PubMed ID: 8483502
[TBL] [Abstract][Full Text] [Related]
17. De-novo design of complementary (antisense) peptide mini-receptor inhibitor of interleukin 18 (IL-18).
Bhakoo A; Raynes JG; Heal JR; Keller M; Miller AD
Mol Immunol; 2004 Nov; 41(12):1217-24. PubMed ID: 15482857
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of interleukin-13 and insights into receptor engagement.
Eisenmesser EZ; Horita DA; Altieri AS; Byrd RA
J Mol Biol; 2001 Jun; 310(1):231-41. PubMed ID: 11419949
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 5 in the link between the innate and acquired immune response.
Takatsu K; Kouro T; Nagai Y
Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
[TBL] [Abstract][Full Text] [Related]
20. Compensatory energetic mechanisms mediating the assembly of signaling complexes between interleukin-2 and its alpha, beta, and gamma(c) receptors.
Rickert M; Boulanger MJ; Goriatcheva N; Garcia KC
J Mol Biol; 2004 Jun; 339(5):1115-28. PubMed ID: 15178252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
